white Surgenex logo

Pioneering the future of Medical Solutions

Surgenex® is committed to turning innovative scientific research into industry leading human cellular and tissue-based products.

Capabilities

Birth Tissue Allografts

Learn More

Bone Matrix Implants

Learn More

Acellular Dermal Matrix

Learn More

Dentistry Allografts

Learn More

Structural Allografts

Learn More

Clinical Evaluation

Learn More

Verification & Validation

Learn More

Formulation Optimization

Learn More

Product Development

Learn More

Custom Processing

Learn More

Serving Global Markets

Learn More

Proprietary Processes

Learn More

Tissue Procurement

Donor eligibility is determined by our Surgenex Medical Director.

Processing

Through controlled procedures, the tissue is cleaned, processed, and stored.

Storage

Products are inspected by our Quality Assurance Team and stored in a controlled and monitored environment.

Surgenex CEO Abel Bullock
Abel Bullock
Founder & CEO

Pioneering the future today

Mr. Bullock has decades of experience in the medical industry working for PSS World Medical and McKesson Medical-Surgical. He founded Surgenex in 2014 with the first allograft product launch occurring in July 2015. His previous experience is with creating fast-growth companies with low overhead and operational excellence. He has led the rapid expansion of Surgenex and its product offerings. Mr. Bullock has an International Master's degree in Business from CW POST in New York, the European Business School in London, and the American University of Paris in Paris. Mr. Bullock's undergraduate degree is in Business Management from Missouri State University.

Surgenex CFO Dan Robinson
Dan Robinson
CFO

Focused on Value & Accelerated Growth

Mr. Robinson has nearly two decades of Private Equity and Venture Capital experience in CFO and Controller roles including previous experience working with tissue banks.

Mr. Robinson has worked closely with many entrepreneurs through rapid growth cycles and M&A transaction.  Mr. Robinson has a BS of Accounting and Business Management, and an MBA degree. He is also a Certified Valuation Analyst (CVA), and a Certified Merger and Acquisition Advisor (CM&AA).

Surgenex CQRO
Jackie Warn
CQRO

Ensuring Rigorous Quality In Every Step

Ms. Warn, recognized for her strategic leadership, boasts nearly three decades of experience in quality, regulatory, and performance excellence across various sectors including biotechnology, tissue banking, hospitals, and laboratories. Her expertise lies in developing and spearheading enterprise-wide regulatory affairs and quality management systems, ensuring rigorous adherence to the highest regulatory standards while driving operational process enhancements.

Ms. Warn actively contributes to the field by serving on various committees and councils within the Association for Advancing Tissue and Biologics. Her educational background includes an MBA, a BS in Business Administration, and an AAS in Medical Laboratory Technology. Additionally, she is certified by the American Society of Quality (CMQOE) and the American Society of Clinical Pathologists (MLT).